TrialGenome medicine2025

Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications.

Daniel J Vis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.